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P
LoS Medicine is a sufﬁ  ciently 
new journal that we are often 
doing something for the 
ﬁ  rst time. This issue’s “ﬁ  rst” is the 
publication of a research article that 
reports data exclusively from animals, 
more precisely from six cynomolgus 
macaques used to test the efﬁ  cacy of a 
new Lassa fever vaccine. There 
is no question that animal 
studies are an important 
part of medical research, but 
which ones, if any, belong in a 
medical journal? More to the 
point, which ones belong in 
PLoS Medicine? Although our 
journal’s focus is on human 
studies, we have decided, on 
occasion, to publish animal 
studies that have important 
and proximal implications for 
clinical research, and maybe 
even practice. 
Lassa fever causes serious 
morbidity and mortality in 
West Africa. The virus’s natural 
hosts are rodents, and as there 
is little chance for effective 
rodent control in the endemic areas, 
a vaccine is the most feasible way to 
gain control of the disease. Several 
research groups around the world have 
worked on vaccine development—and 
their efforts have been boosted by the 
classiﬁ  cation of Lassa virus as a Category 
A bioweapons agent—but to date no 
vaccine is available for either general or 
high-risk application in humans. 
Thomas Geisbert and colleagues 
have developed and now report tests 
of a recombinant vaccine based on 
a replication-competent vesicular 
stomatitis virus (DOI: 10.1371/
journal.pmed.0020183). One shot 
of this vaccine protected four out of 
four vaccinated monkeys against a 
lethal virus challenge, whereas the 
two control animals died, making 
the vaccine a serious candidate for 
future application in humans. Clearly 
many issues about this vaccine still 
need to be resolved, such as vector 
safety, duration of protection, and 
breadth of protection (there are at 
least four distinct Lassa virus strains). 
Nevertheless, we accepted this paper 
because we and our advisers felt that 
the research was at a stage where 
clinical questions, such as patient 
safety and design of early human trials, 
should inform any additional studies in 
animals. The proper place for such a 
study is, we believe, a clinical journal. 
There are several other types of 
animal studies we consider appropriate 
for publication in PLoS Medicine. These 
include studies that explore off-label 
uses of approved medical interventions 
in validated animal disease models, 
again based on the studies’ direct 
relevance to potential treatment of 
human patients. More often, we would 
publish human studies that also include 
experimental animal data, which 
typically explore molecular mechanisms 
suggested by the human data. 
Animal studies that are submitted to 
medical journals can be broadly divided 
into two groups—“animal clinical trials” 
and exploratory studies. We will assess 
the former in a similar way to how we 
look at human trials. This assessment 
will include not only the ethical 
conduct of the study and approval by 
the respective regulatory authority, 
but also the rigor of the methodology. 
Too often, animal clinical trials, i.e., 
prospective, hypothesis-testing studies 
that evaluate the effects of a health-
related intervention in animals, are 
not performed with the same rigor that 
has been developed over past decades 
and widely adopted by the clinical 
research community. In particular, 
animal studies often have inappropriate 
controls, are underpowered, involve 
researchers monitoring outcomes who 
are not blinded to treatment allocation, 
or lack proper statistical 
analysis. 
Exploratory studies, 
designed to yield insight into 
disease etiology, pathology, 
or the mechanisms by which 
a particular treatment affects 
a disease state, are a crucial 
early part of the translation of 
basic research ﬁ  ndings into 
clinical practice. However, 
by and large, they will not be 
appropriate for PLoS Medicine. 
Instead, we encourage 
submission of important 
advances from this early 
translational stage to PLoS 
Biology, our ﬂ  agship open-
access biology journal (www.
plosbiology.org). 
It would be foolish to deny the 
existence of a sizeable “grey area” 
between these types of study. Between 
our journals, we will try to provide 
open-access publication for any 
important study at this interface 
between biology and medicine, and will 
be happy to talk with authors on a case-
by-case basis. In addition, we currently 
cross-reference studies between the 
two journals—and will do so even 
more when our new journals come on 
line. For example, PLoS Medicine has 
published a number of Perspectives 
on research articles published in PLoS 
Biology, and PLoS Biology regularly 
highlights papers from PLoS Medicine 
on its home page. In this way, because 
all our journals are open access, the 
difference to the reader between a 
paper published in PLoS Medicine and 
any other PLoS journal, is just a rodent 
click.  
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